Rapid Method of Processing Sperm for Nucleic Acid Extraction in Clinical Research by de Gannes, Matthew K
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Masters Theses Dissertations and Theses 
August 2014 
Rapid Method of Processing Sperm for Nucleic Acid Extraction in 
Clinical Research 
Matthew K. de Gannes 
University of Massachusetts Amherst 
Follow this and additional works at: https://scholarworks.umass.edu/masters_theses_2 
 Part of the Biology Commons, Cell Biology Commons, Cellular and Molecular Physiology Commons, 
Clinical Epidemiology Commons, Environmental Health Commons, Environmental Public Health 
Commons, and the Molecular Genetics Commons 
Recommended Citation 
de Gannes, Matthew K., "Rapid Method of Processing Sperm for Nucleic Acid Extraction in Clinical 
Research" (2014). Masters Theses. 9. 
https://scholarworks.umass.edu/masters_theses_2/9 
This Open Access Thesis is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses by an authorized 
administrator of ScholarWorks@UMass Amherst. For more information, please contact 
scholarworks@library.umass.edu. 
  
 
Rapid Method of Processing Sperm for Nucleic Acid Extraction in Clinical Research 
 
 
A Thesis Presented 
By 
MATTHEW K. DE GANNES 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
May 2014 
 
Public Health 
 
Environmental Health Sciences 
 
  
 
Rapid Method of Processing Sperm for Nucleic Acid Extraction in Clinical Research 
 
 
A Thesis Presented 
By 
MATTHEW K. DE GANNES 
 
Approved as to style and content by: 
 
         
J. Richard Pilsner, Chair 
 
 
         
Alexander Suvorov, Member 
 
 
         
Brian W. Whitcomb, Member 
 
 
         
Paula L. Stamps, Graduate Program Director 
Department of Public Health 
 iii 
 
ACKNOWLEDGMENTS 
 
 It gives me pleasure to mention my advisor, J. Richard Pilsner, for his care and 
support over the last two years. His constant dedication and eagerness to challenge his 
students to achieve excellence have been key contributors to both my personal and 
professional development. I will forever appreciate his invaluable guidance throughout 
my future endeavors. 
 I would also like to thank my colleagues from the laboratory- Haotian Wu, 
Maggie Kwong, Gianna Luchetti, Justin English, Samuel Hildebrand, and Kara Page- 
who have worked many days and nights to help me perfect the methods described in this 
manuscript. 
 I would also like to express gratitude to the members of my committee, Alexander 
Suvorov and Brian W. Whitcomb, for their helpful comments and suggestions throughout 
the project. 
 Thanks are also due to Kathleen Arcaro and her laboratory, for allowing us access 
to her hemocytometer for counting sperm cells. 
 Finally, I would like to say a special thank you to all those whose support and 
friendship helped me to maintain my focus, and provided me with the encouragement to 
remain strong and work hard when the going got tough. 
 
 
 iv 
 
ABSTRACT 
RAPID METHOD OF PROCESSING SPERM FOR NUCLEIC ACID EXTRACTION 
IN CLINICAL RESEARCH 
MAY 2014 
MATTHEW K. DE GANNES, B.S., GETTYSBURG COLLEGE 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor J. Richard Pilsner 
Background: Sperm contain compact nuclei, inhibiting DNA extraction using traditional 
somatic cell techniques. Previous methods extracted quality sperm DNA using reducing 
agents, but with lengthy lysis procedures and no means of stabilizing DNA. These 
limitations hamper efficient clinical research. 
Objective: We sought to optimize an efficient method of extracting high quality, 
molecular weight DNA from human sperm suitable for clinical research. 
Methods: Sperm from semen samples provided by three volunteers were isolated using 
modified PureCeption Gradient protocol. We tested 1) proteinase K in the presence of 
DNA/RNA Shield, 2) dithiothreitol (DTT) and tris(2-carboxyethyl)phosphine (TCEP) as 
reducing agents, 3) QIAshredder for sperm cell homogenization, and 4) the stability of 
sperm DNA by performing DNA extractions using modified Quick-gDNA MiniPrep 
protocol on sperm samples immediately (baseline) or after four weeks of storage at 4OC 
in DNA/RNA Shield. DNA was amplified by PCR using ALU primers and digested with 
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Hinf1 restriction enzymes. Imprinted DNA methylation was assessed using 
MassARRAY.  
Results: Treatment with proteinase K produced similar DNA concentrations 
(30.1+0.28ng/µL and 33.4+0.21ng/µL) compared to without proteinase K in DNA/RNA 
Shield (28.9+0.00ng/µL and 30.9+0.85ng/µL). No sperm cells were observed after 1 
minute with 25mM TCEP treatment compared to 20 minutes with 100mM DTT. Lysis 
with 50mM TCEP produced greater DNA concentrations (17.2+0.50ng/µL and 
21.3+0.71ng/µL) compared to 50mM DTT (12.6+0.28ng/µL and 12.3+0.35ng/µL). 
QIAshredder with 50mM TCEP increased DNA concentrations (25.9+0.35ng/µL and 
21.7+0.49ng/µL) compared to 50mM TCEP alone (18.6+0.99ng/µL and 
12.3+0.35ng/µL). DNA concentrations at baseline (36.2+2.75 ng/µL, 32.2+1.38ng/µL, 
and 44.3+3.93ng/µL) were similar to those after 4 weeks (40.0+2.98ng/µL, 
37.6+1.38ng/µL, and 38.7+3.93ng/µL). DNA from both storage times was successfully 
amplified by PCR using ALU primers and efficiently digested with Hinf1 restriction 
enzymes. MassARRAY revealed similar percentages of methylation at baseline and 
4weeks of storage for SNURF (1.43+1.02%, 1.55+0.95%), PEG10 (3.69+0.66%, 
4.28+1.52%), and H19 (88.93+3.24%, 91.78+2.00%) imprinted loci. 
Conclusions: We isolated high quality, molecular weight DNA from human sperm using 
5 minute versus > 2 hour lysis in other methods. DNA/RNA Shield stabilized sperm 
DNA over 4 weeks. Our methods may facilitate efficient clinical research essential to 
investigate the role of sperm genetics and epigenetics in male reproductive health. 
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CHAPTER 1 
INTRODUCTION 
1.1 The Importance of Sperm to Male Reproductive Health 
 Epidemiological data estimate that 6-8% of the United States population was 
infertile between 1982-2010 [1] and male factors contributed to nearly half of these cases 
[2]. Furthermore, the decline in fertility observed between 1982-2000 was accompanied 
by an overall decline in human semen quality [3]. Several epidemiological and animal 
studies have revealed that there are key genetic [4-8] and epigenetic [9-13] factors 
essential to proper spermatogenesis and male reproductive health. An overview of the 
spermatogenesis process and the importance of key genetic and epigenetic factors to this 
process are discussed below. 
1.2 Spermatogenesis and Sperm Biology 
1.2.1 Stages of Spermatogenesis and Cell Division 
 In the seminiferous epithelium, germ cells form several concentric layers 
penetrated by somatic cells called Sertoli cells. The Sertoli cells extend around all the 
germ cells to nurture and maintain their cellular associations throughout spermatogenesis 
[14]. Germ cell differentiation is precisely regulated so that the same stages of 
spermatogonia, spermatocytes, round spermatids, and late spermatids are always found in 
association [15]. Because the differentiation process is spatially synchronized, a given 
cross section of seminiferous tubule most often has germ cells at the same stage of 
spermatogenesis. The presence of regularly repeating cell associations in a given tubule 
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cross section allowed Leblond and Clermont to identify 14 stages of spermatogenesis in 
the rat [16] and Oakberg to identify 12 stages in the mouse [17]. The process of 
spermatogenesis is summarized in Figure 1 taken from Anatomy and Physiology [18]. 
 
Figure 1: Summary of the process of spermatogenesis from primary spermatocytes to 
spermatozoa. This summary was taken from Anatomy and Physiology [18]. 
 Spermatogenesis is a precisely timed and highly organized process by which 
haploid spermatozoa are produced from diploid spermatogonial stem cells. The process 
begins at puberty, after which sperm are produced constantly (200 to 300 million daily) 
until age 35 in humans, when sperm production begins to slowly decline [18,19]. One 
cycle of spermatogenesis, from spermatogonia through mature sperm, takes 
approximately 64 days with a new cycle occurring every 16 days [18]. The cycle begins 
with mitosis of diploid spermatogonia on the basement membrane of seminiferous 
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tubules [18]. Type A1 spermatogonia, containing dark nuclei, divide mitotically and 
reproduce themselves (homonymous division), maintaining the spermatogonia population 
[20]. Type A2 spermatogonia, containing pale nuclei, may divide mitotically to produce 
type A3 and then A4 spermatogonia. The type A4 spermatogonium can 1) form another 
A4 spermatogonium (self-renewal), 2) undergo cell death (apoptosis), or 3) differentiate 
into an intermediate spermatogonium (heteronymous division) which is inducted into 
spermatogenesis. Intermediate spermatogonia divide once mitotically to form type B 
spermatogonia that also divide mitotically into primary spermatocytes. It is not known 
what causes the spermatogonia to take the path toward spermatogenesis rather than self-
renewal [21]. 
 Mitosis is followed by the first meiotic division where DNA is replicated and the 
chromosome number is halved in the primary spermatocyte [18]. Chromosome pairs 
undergo homologous recombination involving the formation of synaptonemal complexes 
in which double strand breaks occur [22]. Genetic material is then exchanged between 
maternal and paternal chromosomes during repair of the breaks. At the end of the first 
meiotic division, two secondary spermatocytes with identical chromosomes are produced 
[18]. The second meiotic division involves the separation of individual chromatid strands 
to produce four haploid, spherical cells called spermatids [18]. 
 Following meiosis, the differentiation of spermatids occurs through a process 
called spermiogenesis. This occurs in 4 phases: Golgi, capping, acrosomal, and 
maturation [14]. The Golgi apparatus of these early spermatids produce vesicles and 
granules containing enzymes that will cover the developing sperm nucleus. A single large 
acrosomal granule within a larger vesicle indents the nucleus and the vesicle begins to 
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flatten into a small cap over the nuclear surface. The acrosomic vesicle becomes very 
thin, the granule flattens, and the new acrosome flattens over the nuclear surface of the 
elongating spermatid. The nuclei also begin to change shape as condensation of 
chromatin and replacement of histones with protamines occurs, and the nucleus becomes 
more compact [23]. 
 The maturation phase has fewer changes in nuclear shape and acrosomal 
migration, but the nucleus continues to condense. The acrosome matures into a thin 
structure that protrudes at the apex, covering nearly all of the nucleus except for the 
portion connected to the tail [14]. The cytoplasm is reduced, resulting in the formation of 
cytoplasmic lobes and residual bodes which contain unused mitochondria, ribosomes, 
lipids, vesicles, and other components [14]. The end result of this process occurs in the 
final stage of spermatogenesis, in the portion of the tubule nearest the lumen, where 
spermatozoa are formed [18]. The spermatozoa are released into the lumen and then 
migrate through a series of ducts toward the epididymis where they mature further and 
slowly acquire the ability to move on their own. The motility of sperm is dependent on 
ATP produced by tightly packed mitochondria that fill the mid-piece of the sperm. The 
ATP powers the flagellum, which extends from the neck through the tail of the sperm, 
enabling the sperm to move [18]. The structure of a fully mature sperm is illustrated in 
Figure 2 taken from Anatomy and Physiology [18]. 
 5 
 
 
Figure 2: The structure of a fully mature sperm. Each sperm cell is divided into a head 
containing DNA, mid-piece containing mitochondria, and tail providing motility. This diagram 
was taken from Anatomy and Physiology [18]. 
1.2.2 Histone Replacement with Protamines 
 The sperm cell has a specialized architecture which allows it to traverse the 
potentially hostile environment of the female reproductive tract and fertilize the human 
egg [24]. Dramatic changes to sperm chromatin structure occur during spermiogenesis, 
whereby 90-95% of histones are replaced with protamines [25]. Protamination of sperm 
chromatin allows the nuclear compaction necessary for sperm motility and helps to 
protect the genome from oxidation and harmful molecules within the female reproductive 
tract [25]. Furthermore, because the higher order packaging of DNA after protamination 
precludes transcriptional activity, protamination is a nontraditional form of epigenetic 
regulation unique to sperm cells [23]. 
 The replacement of histones with protamines is a multistep process and is 
summarized in Figure 3  taken from Carrell et al. [26]. First, there is an increase in site-
specific acetylation, methylation, phosphorylation, and ubiquitnation of histones which 
facilitate their replacement by testis-specific histones (H-t) that are expressed during 
spermatogenesis [26,27]. The hyperacetylation of H4-t is a key factor that produces a 
relaxed chromatin structure important for facilitating topoisomerase-induced double-
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stand breaks and replacement of histones with transition proteins [28,29]. Transition 
proteins 1 and 2 (TP1 and TP2) are proteins of intermediate basicity that bind to DNA, 
allowing removal of histones and subsequent protamine compaction [30]. 
 
Figure 3: Diagram highlighting the key events in the transition of histones to replacement 
by protamines. Histones undergo site-specific acetylation, methylation, phosphorylation and 
ubiquitination which facilitate their replacement by testis-specific histones (H-t) during meiosis. 
Hyperacetylation of H4-t is a key factor that produces a relaxed chromatin structure important for 
facilitating topoisomerase-induced double-stand breaks and replacement of histones with 
transition proteins. Protamines 1 and 2, processed from a pool of RNP particles, undergo 
maturation before and during binding to the DNA and replacement of the transition proteins. 
Legend: HR6B, ubiquitin-conjugating enzyme E2B (UBE2B) (RAD6 homolog); HAT, histone 
acetyltransferase; Suv39, H3 Lys 9 histone methyltransferase. This diagram was taken from 
Carrell et al. [26]. 
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 In the next step, transition proteins are completely replaced by protamines. 
Protamines 1 and 2 (P1 and P2) are processed from a pool of ribonucleoprotein (RNP) 
particles and undergo maturation before and during binding to the DNA and replacement 
of transition proteins [26]. In healthy, fertile individuals, P1 and P2 are expressed in 
roughly equal quantities [31]. Efficient chromatin packaging and compaction of the 
sperm nucleus is dependent upon proper protamine replacement. The formation of 
disulfide bonds between the protamines and the formation of toroidal chromatin 
structures facilitates nuclear compaction [32]. Because this compaction renders the sperm 
nucleus resistant to damage from harmful molecules, high quality nucleic acids cannot be 
extracted from sperm using traditional somatic cell techniques [33]. 
 Despite the replacement of histones with protamines, 5-10% of DNA in fertile 
men, and more in infertile men, remain bound to histones [34,35]. Ward has proposed a 
model illustrating the structural arrangement of histone- and protamine bound regions of 
DNA in mature sperm in which histones are interspersed between protamine toroids and 
may be bound to matrix attachment regions associated with linker regions [36,37]. The 
model shows the protection of protamine-bound DNA from damage by toroidal 
compaction, and the vulnerability of histone-bound and linker regions to DNA 
degradation by endonucleases [38]. This model has important implications in studies 
where the proper functioning of sperm and associated male fertility can be investigated 
through proper replacement of histones with protamines [39,40]. 
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1.3 Spermatogenesis and Genetics 
 In mammals, many more germline cell divisions occur in the life of a sperm 
compared to an egg because sperm are produced continuously throughout adult life, 
unlike eggs where all cell divisions are completed before birth [4]. As the human male 
ages, the number of cell divisions and chromosome replications increases, rendering the 
sperm susceptible to increased de novo mutations [4,5]. Double strand breaks and DNA 
repair during spermatogenesis is important for the genomic integrity of future haploid 
sperm. One study showed that the loss of the nuclear protein PTIP, implicated in the 
DNA damage response, in male mice resulted in cessation of spermatogenesis, testicular 
atrophy, and a near complete lack of spermatozoa [22]. It has been proposed that the 
increased de novo mutations may be the result of reduced fidelity of DNA replication and 
efficiency of DNA repair mechanisms, which normally decline with age [41]. 
 Epidemiological studies suggest associations of de novo mutation rates in the 
male germline with paternal age that increase the risk for disease in offspring, including 
achondroplasia, Apert syndrome, schizophrenia, and autism spectrum disorders [4-8]. 
One study estimated the odds ratio (OR) comparing non-synonymous to silent mutations 
in affected autistic individuals (probands) and their unaffected siblings across 200 
families [6]. The total number of non-synonymous de novo single nucleotide variants 
(SNVs) was significantly greater in probands compared to unaffected siblings. Probands 
also had double the odds of having non-synonymous mutations versus silent mutations 
compared to unaffected siblings (OR = 1.93). The rate of these de novo SNVs was found 
to increase with paternal age [6]. 
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 These findings highlight the importance of sperm genetics to future health and 
development, and underscore the importance of stable and efficient methods for the 
isolation of sperm DNA. 
1.4 Spermatogenesis and Epigenetics 
 Whereas an organism’s genotype is relatively static throughout life, the 
epigenome is highly dynamic. Epigenetic alteration is defined as any heritable change in 
gene expression potential without a change in DNA sequence [42]. These alterations 
occur in response to the internal and external environment, and include DNA 
methylation, non-coding RNA, and histone modifications. Because of its role in the 
regulation of gene expression, it is critical to development and disease. The epigenome is 
reprogrammed in the gametes and embryo from generation to generation, allowing for 
totipotency and preventing the transmission of epigenetic error [43]. However, because 
not all regions of the epigenome are reprogrammed, the transmission of epigenetic 
information from parents to offspring may occur [9]. Therefore, epigenetic information 
passed on by gametes may provide information on parental environmental exposures. To 
date, the mechanisms underlying epigenetic inheritance are largely unknown, and there is 
a lack of evidence to support epigenetic transmission via the sperm. 
 DNA methylation is the most characterized epigenetic modification and, in 
mammals, occurs almost exclusively at the 5-position of cytosine residues within CpG 
dinucleotides [44]. DNA methylation is catalyzed by DNA methyltransferases and 
coordinates with other epigenetic modifications to suppress gene expression [45]. Briefly, 
methyl-CpG-binding protein 2 binds methylated CpGs and recruits chromatin-remodeling 
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complexes and histone deacetylases [46]. This leads to chromatin condensation which 
results in limited accessibility of the transcriptional machinery to promoter regions, 
suppressing gene expression. 
 DNA methylation is essential for allele-specific imprinting, a non-Mendelian 
“parent-of-origin” form of mono-allelic inheritance. For an imprinted gene, either the 
paternal (if the gene is maternally-expressed) or maternal (if the gene is paternally-
expressed) allele is heavily methylated (imprinted). Imprinting differs from bi-allelic 
expression, the traditional, Mendelian form of inheritance where both parental alleles are 
equally expressed for a given gene. For imprinted genes present in somatic cells, about 
50% methylation is expected because only one of the alleles is imprinted. For gametes, 
however, only one allele is present per gene after meiosis, therefore either complete 
(100%) or no (0%) methylation is expected, depending on whether the gamete is male or 
female. Therefore, for human sperm, complete and no methylation would be expected for 
maternally-expressed and paternally-expressed imprinted genes, respectively. 
 In primordial germ cells, during gonadal sex determination, parental methylation 
marks are reset and subsequently re-established in a sex-specific manner during 
gametogenesis, where haploidization occurs [43]. Methylation marks in imprinted genes 
and repeat regions are then maintained through fertilization into adulthood and other 
marks undergo de-methylation. This process of epigenetic erasure and subsequent 
reprogramming is essential for sperm maturation and represents a critical window of 
susceptibility during which environmental agents may adversely influence epigenetic 
regulation [9]. 
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 Previous studies of DNA methylation in sperm revealed unique patterns compared 
with somatic cells [34,47,48]. Overall, the sperm genome has been shown to be 
hypomethylated compared to differentiated somatic cells, particularly at histone-enriched 
promoters of developmental genes involved in spermatogenesis, cell cycle, cell 
metabolism, and embryogenesis. These patterns are necessary to package and poise the 
sperm genome for spermatogenesis and future embryonic development [35]. If these 
patterns and imprinting of genes are disturbed during spermatogenesis, gene expression 
essential for proper development may be compromised in the resulting offspring [49]. 
Alterations in the sperm epigenome have also been associated with male fertility issues 
such as low sperm count, motility, and morphology [9-11] as well as overall male 
infertility [12,13]. 
1.5 Summary 
 Previous literature has indicated that sperm possess key biomarkers for proper 
spermatogenesis as well as successful embryonic development after fertilization. In 
particular, assessments of developmental players during spermatogenesis from both a 
genetics and epigenetics standpoint, through polymorphisms and mutations as well as 
DNA methylation, may be utilized as clinical markers of male reproductive health. 
However, nuclear compaction due to the replacement of histones with protamines 
precludes the extraction of high quality DNA using traditional somatic cell techniques. 
Therefore, the need for an efficient DNA extraction protocol for human sperm suitable 
for clinical research is required. 
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CHAPTER 2 
LITERATURE REVIEW OF DNA EXTRACTION METHODS 
 A wide array of techniques exists to isolate high quality and molecular weight 
DNA from mammalian somatic cells. However, these techniques are ineffective for 
mammalian sperm [50,51]. This is because unlike in somatic cells, in sperm cells nearly 
all histones are replaced by protamines held together by disulfide bonds, compacting the 
sperm nucleus and thus rendering it resistant to conventional lysis procedures [38]. 
2.1 Sperm DNA Extraction 
 The development of efficient methods for isolating DNA from mammalian sperm 
has been a gradual process. Bahnak et al. reported a protocol using guanidine thiocyanate 
in a lysis buffer made with sodium citrate, sodium lauroyl sarcosinate (Sarkosyl), and β-
mercaptoethanol (reducing agent) to isolate high quality mammalian sperm DNA[50]. 
The DNA extracted was then successfully visualized during Southern blot analysis. 
However, the procedure was tedious, requiring lengthy steps such as CsCl 
ultracentrifugation for 20 hours and dialyzing the banded DNA for 24 hours against Tris-
HCl and ethylenediaminetetraacetic acid (EDTA). 
 The inclusion of proteinase K in subsequent methods to enhance the activity of 
chaotropic agents such as guanidine thiocyanate by digesting nucleoproteins eliminated 
the need for lengthy ultracentrifugation and dialyzing steps. In a method developed by 
Pacheco et al. [52], sperm pellets were lysed for 16 hours in a solution containing Tris-
HCl, dithiothreitol (DTT; another commonly used reducing agent), sodium chloride, 
EDTA, sodium dodecyl sulfate (SDS), proteinase K, and β-mercaptoethanol. DNA was 
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then extracted using a phenol/chloroform protocol, and DNA was ethanol precipitated. 
While the authors were able to extract DNA used for subsequent DNA methylation 
analyses, the method still required at least an overnight incubation. The method also 
employed the use of harmful organic solvents (phenol and chloroform) that are 
undesirable for simple laboratory procedures. 
 The method developed by Hossain et al.[53] was one of the first to eliminate 
overnight procedures from the sperm DNA extraction protocol. Hossain et al. modified 
the original protocol by Bahnak et al. for the preparation of human sperm DNA by 
including proteinase K in the lysis buffer (containing guanidinium thiocyanate) to digest 
nucleoproteins, and isopropanol to precipitate DNA. This modification eliminated the 
need to mechanically homogenize the cells, use organic solvents for extraction, and use 
ultracentrifugation for DNA precipitation. Therefore, the degradation of DNA through 
mechanical homogenization and organic solvents was minimized, and the overall 
procedure could be performed in ordinary laboratory facilities in a reduced amount of 
time (only an incubation period of 3 hours for lysis was required). However, incomplete 
protein digestion and removal of chaotropic salts persisted, limiting the quality of the 
DNA yield [33]. 
2.1.1 Griffin’s DNA Extraction Method 
 A recent method by Griffin is worth highlighting because modifications were 
made to Hossain’s protocol to increase the quality and yield of mammalian sperm DNA 
by eliminating incomplete protein digestion and removal of chaotropic salts that may 
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coprecipitate with DNA [33]. Descriptions of the lysis and extraction components as well 
as the steps of and modifications to Hossain’s protocol were provided in detail [33]. 
 Guanidine thiocyanate is one variety of chaotropic agent employed during DNA 
extractions. Its functions include 1) disruption of the hydrate shell of DNA, rendering it 
insoluble in aqueous solutions, 2) irreversible inactivation of RNases and DNases, 3) 
disruption of the hydrophobic structures of proteins, metabolites, and other contaminants 
so that they become soluble in aqueous solutions, and 4) disintegration of cellular 
membranes. Guanidine thiocyanate enhances the activity of proteinase K, an enzyme that 
aids in protein solubilization and lysis. Creating hydrophobic and hydrophilic 
environments for DNA and proteins respectively is necessary to 1) help bind the DNA to 
the hydrophobic silica membrane of spin columns in commercial extraction kits and 2) 
remove proteins and other contaminants during subsequent washing steps. 
 The replacement of histones with protamines, which are held together by disulfide 
bonds, compacts the sperm nucleus and renders it resistant to DNA extraction by 
traditional somatic cell methods. Therefore, the use of reducing agents to dissociate 
protamines from DNA using strong reducing agents is required. DTT and β-
mercaptoethanol are examples of such reducing agents which cleave disulfide bonds and 
allow proteins to unfold [33]. Griffin employed DTT in the lysis buffer because it is more 
effective and less toxic, works more efficiently, and has a milder odor compared to β-
mercaptoethanol. Furthermore, even though SDS has previously been used in DNA 
extractions, it has a very low solubility in high-salt chaotropic solutions. Griffin 
employed Sarkosyl in the lysis buffer because it is soluble in high-salt chaotropic 
solutions and, like SDS, is used to denature proteins and disrupt cellular membranes [33]. 
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Overall, lysis was completed within 2 hours, whereas 3 hours was used in Hossain’s 
protocol. After lysis, the addition of isopropanol allowed precipitation of DNA, and two 
subsequent washes with alcohol and sodium citrate removed any chaotropic salts into 
solution. 
 The extraction method resulted in high quality, high molecular weight genomic 
DNA, with a yield of approximately 80%, an A260/280 ratio ranging between 1.8 and 
2.0, and an A260/230 ratio of 2.0 and greater (as expected for pure DNA) [33]. The DNA 
was also efficiently digested with restriction enzymes and amplified by PCR [33]. 
 Despite these desirable results, a few issues do not make Griffin’s sperm DNA 
extraction protocol ideal for clinical research: 1) The lack of a protocol to stabilize DNA, 
2) The lengthy period taken for lysis (2 hours), 3) The unpleasant sulfur odor of DTT 
[54] and 4) DTT becomes unstable in solution and must be prepared fresh for every 
extraction [54]. The lack of a means to prevent the degradation of DNA yield and quality 
may potentially increase the cost of clinical research because degraded sperm DNA 
would need to be constantly replaced with new samples obtained from volunteers. In 
addition, the lengthy period for lysis coupled with the need to prepare fresh DTT for each 
sperm DNA extraction would make Griffin’s methods inefficient for studies requiring 
large sample sizes. Therefore, Griffin’s methods may only be suitable for applications 
where few patients or volunteers are required to be tested over a short period such as in 
fertility clinics. Because clinical research typically involves large sample sizes over 
potentially large time periods, a more efficient method is required where large numbers 
of sperm samples can be collected and stored for long durations until DNA extraction and 
analysis begins. 
 16 
 
2.2 Summary 
 Table 1 presents a summary of the methods developed for extracting sperm DNA. 
The most recent method by Griffin for DNA extraction provides a promising approach 
for consistently attaining high-quality yields of DNA [33,55]. Furthermore, this approach 
has been validated by quality control methods that demonstrate 1) the ability to visualize 
sperm genomic DNA on an agarose gel, 2) the ability to perform restriction enzyme 
analysis, and 3) amplification of target regions using qPCR, However, the methods 
involve a lengthy lysis procedure (2 hours) and lack a suitable storage procedure for 
maintaining stable yields of DNA. These limitations may hamper efficient clinical 
research for investigating male reproductive health. In addition, even though several 
studies have been able to obtain DNA for downstream epigenetic profiling 
[9,34,35,39,56], none have incorporated the recent methods by Griffin. 
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Table 1: Summary of the development of methods for the extraction of DNA from human 
sperm. 
 
 For the present study, we have optimized a rapid, simple method of extracting 
high quality, high molecular weight genomic DNA from human sperm. Because we were 
able to stabilize sperm DNA for 4 weeks and reduce the duration of lysis procedures to 
five minutes at room temperature, our methods may be preferred to existing approaches 
for clinical research where procedure time and viable sample storage duration are 
important criteria. In addition, we have performed several downstream quality control 
procedures: 1) PCR amplification of genomic DNA using ALU primers, 2) Hinf1 
restriction enzyme digestion and analysis, and 3) DNA methylation analysis using 
selected maternally and paternally imprinted genes. 
 
 
Author, year Lysis Buffer Reducing Agent Procedure Time Advantages Disadvantages
Bahnak et 
al., 1988
Guanidine thiocyanate, 
β-mercaptoethanol, 
Sarkosyl, sodium citrate
 β-mercaptoethanol 20+ hours 
ultracentrifugation 
and dialysis.
One of the first to 
isolate high quality 
sperm DNA.
Lengthy 
ultracentrifugation (20 
hrs) and dialyzing 
steps (24 hrs).
Hossain et 
al., 1997
Guanidine thiocyanate, 
β-mercaptoethanol, 
Sarkosyl, sodium citrate 
and Proteinase K
β-mercaptoethanol 3 hours Eliminated need for 
mechanical 
homogenization, use of 
organic solvents, and 
ultracentrifugation; 
could be performed in 
ordinary laboratories; 
Lysis was completed in 3 
hours.
Incomplete protein 
digestion and removal 
of chaotropic salts.
Pacheco et 
al., 2011
Tris, DTT, sodium 
chloride, EDTA, SDS, 
proteinase K, β-
mercaptoethanol
DTT and β-
mercaptoethanol
16 hours
Lysis could be 
performed at room 
temperature in ordinary 
laboratory facilities.
A lengthy overnight 
incubation is required;
Use of harmful organic 
solvents (chloroform) 
required.
Griffin, 2013 Guanidine thiocyanate, 
DTT, Sarkosyl, sodium 
chloride, and 
Proteinase K
DTT 2 hours Eliminated incomplete 
protein digestion and 
removal of chaotropic 
salts. Lysis completed in 
2 hours.
Lack methods to 
stabilize sperm DNA; 
lysis time not ideal for 
clinical research.
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CHAPTER 3 
METHODS 
3.1 Sperm Cell Isolation 
 To isolate and purify sperm cells and prepare them for DNA extraction, fresh 
semen samples were collected from three healthy volunteers (n=3) who were required to 
have a period of at least 48 hours of abstinence. Sperm cells were then isolated using a 
modified Continuous One-Step PureCeption Gradient (SAGE Form #81804) protocol. 
The process of isolating human sperm is summarized in Figure 4. This study was 
approved by the Institutional Review Board of the University of Massachusetts. 
 
Figure 4: Summary flow diagram illustrating the steps of sperm cell isolation, purification, 
and storage for DNA extraction. 
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 First, PureCeption 100% Isotonic Solution (SAGE Ref #ART-2100) and Quinn’s 
Sperm Washing Medium (SAGE Ref #ART-1006) were brought to 37OC. A 90% 
PureCeption solution was made by adding 1 volume of Quinn’s Sperm Washing Medium 
to 9 volumes of PureCeption 100% Isotonic Solution. In a conical centrifuge tube, 1.5-
2.0mL of fresh liquefied semen was gently layered on top of 1.0mL of the prepared 90% 
PureCeption. If the semen volume was greater than 2.0mL, more than one tube of 90% 
PureCeption was used. The tube was then centrifuged for 30 minutes at 500 x g. The 90% 
PureCeption and seminal fluid were carefully removed without disturbing the sperm 
pellet, leaving a small amount of 90% PureCeption over the sperm pellet. 
 After transferring the sperm pellet in residual 90% PureCeption solution to a clean 
conical centrifuge tube, the pellet was resuspended in 4mL of Quinn’s Sperm Washing 
Medium. The tube was then centrifuged at 500 x g for five minutes to wash away residual 
90% PureCeption. One mL of washed sample was transferred to a new 1.5mL 
microcentrifuge tube of which 20µL of the washed sample was transferred to a 0.6mL 
microcentrifuge tube for cell counting. The 20µL cell counting aliquot was immediately 
stored at -30OC. The sample was centrifuged for 1 minute at maximum speed and the 
supernatant was removed from the sperm pellet. The sperm pellet was stored in an 
appropriate volume (see methods below) of DNA/RNA Shield (Zymo Research Cat # 
R1100-1-50) and was then lysed and homogenized for future DNA extractions (see 
“Sperm Lysis and Homogenization” and “DNA Extraction” methods below). If the sperm 
sample in DNA/RNA Shield was not used immediately, it was stored at 4OC. 
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3.2 Testing the Utility of Proteinase K Treatment 
 DNA/RNA Shield contains a high concentration of chaotropic guanidine 
thiocyanate such that all nucleoproteins may dissolve in solution. If all nucleoproteins 
dissolve in solution, the need for proteinase K to digest these proteins may be eliminated. 
We therefore tested the hypothesis that the addition of proteinase K in lysis steps 
involving DNA/RNA Shield has no discernable effect on sperm DNA concentrations. 
After removing the supernatant from the 1mL washed sample, the sperm pellet was 
resuspended in 300µL of DNA/RNA Shield. Two separate mixtures made up to a total 
volume of 300µL were made with and without 25mg/mL proteinase K (Promega Part # 
9PIV302) to make a 1:1 dilution of DNA/RNA Shield with nuclease-free water as 
follows: 1) Mix with proteinase K (150µL sperm cells in DNA/RNA Shield, 144µL of 
nuclease-free water, 3µL (0.01M) of 1M DTT (Promega, Cat # V3151), 3µL (75µg) of 
proteinase K) or 2) Mix without proteinase K (150µL of sperm cells in DNA/RNA 
Shield, 147µL of nuclease-free water, 3µL (0.01M) of DTT). The mixtures were 
incubated for 1 hour at 56OC and a modified protocol from the Quick-gDNA MiniPrep 
Kit (Zymo Research Cat # D3025) was used to extract the sperm DNA, starting with the 
addition of Genomic Lysis Buffer from the extraction kit in a 3:1 ratio (see “DNA 
Extraction” method below). DNA yields and quality were then determined using the 
Nanodrop 2000 Spectrophotometer (Thermo Scientific, Listing # E112352). 
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3.3 Comparing the Effectiveness of Different Reducing Agents 
3.3.1 Sperm Cell Counting for Time-Course Experiment 
 Tris(2-carboxyethyl)phosphine (TCEP) has been demonstrated to be an odorless 
reducing agent, more stable and more powerful than the commonly used reducing agent, 
DTT [54]. Therefore, we compared the effectiveness of TCEP to DTT as reducing agents 
for sperm DNA extraction using a time-course experiment. We hypothesized that 
treatment of sperm cells with TCEP would result in more efficient sperm cell lysis than 
DTT. Isolated sperm pellets that were stored at -20OC were treated with duplicates of 
25mM Bond-Breaker TCEP Solution Neutral pH, 0.5M (Thermo Scientific Prod 
#77720), and 100mM of DTT. As a negative control, we also treated sperm pellets with 
200µL of DNA/RNA Shield. Sperm cells were counted at regular time intervals for a 
period of 20 minutes under each counting square of a Bright-Line Hemocytometer (AO 
Scientific Instruments Cat # 1483) using an inverted light microscope (Donsanto 
Corporation Model TMS-F No. 210744) at 40X magnification. The mean number of cells 
remaining per mL of cell suspension was calculated using the following formula: 
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The value 250000/2 represents the dimensions of a single counting square and the 
dilution factor represents the factor used to dilute the original cell suspension. 
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3.3.2 Comparison of DNA Yields Obtained Using DTT and TCEP 
 We tested the hypothesis that treatment of sperm cells with TCEP would result in 
greater sperm DNA concentrations than DTT. To the 1mL washed sample obtained from 
sperm cell isolation, 100µL of DNA/RNA Shield and either 5µL of 1M DTT or 10µL of 
500mM TCEP were added to make 50mM solutions of DTT and TCEP. The samples 
were then pulse vortexed for 15 minutes using the Pulse Vortex Mixer (Fisher Scientific 
Cat # 02215375) and a modified protocol from the Quick-gDNA MiniPrep Kit was used 
to extract the sperm DNA, starting with the addition of Genomic Lysis Buffer from the 
extraction kit in a 3:1 ratio (see “DNA Extraction” method below). DNA yields and 
quality were then determined using the Nanodrop 2000 Spectrophotometer. 
3.4 Testing the Utility of QIAshredder Columns for Sperm Cell Homogenization 
 We tested whether QIAshredder columns (Qiagen Cat # 79656), when used 
together with TCEP to homogenize and lyse sperm cells, would increase DNA yield 
compared to using TCEP alone. We hypothesized that QIAshredder homogenization 
following sperm lysis steps would increase sperm DNA concentrations. To an isolated 
sperm pellet, 360µL of DNA/RNA Shield and 40µL (50mM) of TCEP were added. The 
sperm sample was then pulse vortexed for 5 minutes using the Pulse Vortex Mixer. Using 
the QIAshredder kit, 200µL of the sperm sample were centrifuged for 2 minutes at 
maximum speed through QIAshredder columns and collected in collecting tubes. A 
modified protocol from the Quick-gDNA MiniPrep Kit was used to extract sperm DNA 
from the 200µL sperm samples that did and did not undergo QIAshredder 
homogenization, starting with the addition of Genomic Lysis Buffer from the extraction 
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kit in a 3:1 ratio (see “DNA Extraction” method below). DNA yields and quality were 
then determined using the Nanodrop 2000 Spectrophotometer. 
3.5 Optimized Sperm Cell Lysis and Homogenization 
 After removing the supernatant from the 1mL washed sample during sperm cell 
isolation, the sperm pellet was resuspended in 900µL of DNA/RNA Shield and 100µL 
(50mM) of 500mM TCEP to lyse the cells. The sample was then incubated at room 
temperature for 5 minutes, with occasional pulse vortexing using the Pulse Vortex Mixer. 
After incubation, the sample was centrifuged in a QIAshredder column for 2 minutes at 
maximum speed. If the sperm cells were not used immediately, they were stored at 4OC 
for 1 month. 
3.6 DNA Extraction 
 Guanidine thiocyanate is a chaotropic agent that removes nucleoproteins into 
solution by destabilizing hydrophobic interactions and hydrogen bonds. Because 
DNA/RNA Shield contains a high concentration of guanidine thiocyanate, it would be 
expected to remove nucleoproteins that degrade DNA such as DNAses into solution, 
stabilizing any DNA in suspended cells. Therefore, using our fully optimized sperm 
isolation and DNA extraction protocol (Appendix A), we compared the stability of fresh 
and 4-week-old sperm samples stored at 4OC in DNA/RNA Shield, hypothesizing that the 
samples would yield similar DNA concentrations. A modified protocol from the Quick-
gDNA MiniPrep Kit was used to isolate and purify genomic DNA from fresh and 4-
week-old sperm samples. Genomic Lysis Buffer from the kit was added to the sperm 
pellet suspended in DNA/RNA Shield and TCEP in a 3:1 ratio. The mixture was then 
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vortexed for 4-6 seconds and transferred to the kit’s spin column in a collection tube. The 
tube was centrifuged at 10,000 x g for 1 minute and the collection tube was discarded. 
 After transferring the spin column to a new collection tube, 200µL of the kit’s 
DNA Pre-Wash Buffer was added to the column and centrifuged at 10,000 x g for 1 
minute. Two washes were then performed by adding 500µL of the kit’s g-DNA Wash 
Buffer to the spin column and centrifuging at 10,000 x g for 1 minute. The spin column 
was incubated at room temperature for 5 minutes and transferred to a clean 
microcentrifuge tube. 
 To elute the DNA, 100µL of the kit’s DNA Elution Buffer was added to the spin 
column. The spin column was then incubated for 3 minutes at room temperature and 
centrifuged at maximum speed for 30 seconds to elute the DNA. The yield and quality of 
the DNA were then determined using Nanodrop 2000 Spectrophotometer. If the DNA 
was not used immediately, it was stored at 4OC for future use. 
3.7 PCR and Restriction Digest of Sperm DNA 
 As a quality control we tested the hypothesis that fresh and 4-week-old sperm 
samples would perform with equal efficacy during ALU PCR and Hinf1 digest. To 
perform PCR of the isolated sperm DNA, individual 10µL PCR reactions were prepared 
using 5.0µL(1X) of 2X GoTaq Hot Start Colorless Master Mix (Promega Ref # M513B), 
1.0µL (0.1µM) of 1µM ALU (446bp product) forward and reverse primer mix (Integrated 
DNA Technologies), 2.0µL of nuclease-free water, and 2.0µL (46ng) of genomic sperm 
DNA. The PCR reaction conditions were as follows: 1) Hot start (94OC) for 2 minutes, 2) 
30 cycles of denaturing (94OC), annealing (68OC), and extension (72OC), each for 30 
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seconds, and 3) final extension (72OC) for 5 minutes. Supplementary Table B.1 presents 
a summary of the properties of the ALU primers. 
 To perform restriction digests of the isolated sperm DNA, individual Hinf1 
restriction digest reactions were prepared using 17.00µL (561ng) of genomic sperm 
DNA, 2.0µL(1X) of 10X CutSmart buffer (New England BioLabs Cat # B7204S), and 
1.0µL (100U) of 10,000U/mL Hinf1 restriction enzyme (New England BioLabs Cat # 
R0155S). The restriction digests were performed by incubating the reactions at 37OC for 
1 hour and then heating at 80OC for 20 minutes to inactivate the enzyme. 
 A 0.7% agarose gel was prepared for electrophoresis and samples were added to 
wells in duplicates as follows: 3µL (69ng) genomic sperm DNA, 5µL ALU PCR product, 
and 7µL (196ng) of Hinf1 digestion products. After electrophoresis was performed at 
300V for 20 minutes, the gel was stained with 0.5µg/mL ethidium bromide solution for 
15 minutes, destained for 15 minutes with deionized water, and visualized using the 
Benchtop Variable Transilluminator (UVP Cat # M-26XV) and BioDoc-It Imaging 
System (UVP Cat # M-26X). 
3.8 Preparing Sperm DNA Samples for DNA Methylation Analysis 
 As an additional quality control, we tested the hypothesis that there would be no 
discernable differences in DNA methylation between fresh and 4-week-old sperm 
samples across SNURF, PEG10, and H19 imprinted loci. The protocol for preparing 
genomic DNA for DNA methylation analysis using matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is 
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summarized in a scheme by van den Boom and Ehrich in Figure 5 [57]. The protocol 
was performed by two different experimenters. 
 
Figure 5: Summary scheme for preparation of bisulfite converted DNA samples for DNA 
methylation analysis using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS). Genomic DNA is bisulfite treated to introduce methylation-
dependent sequence changes and then amplified by PCR. After amplification by PCR, the PCR 
product is treated with shrimp alkaline phosphatase (SAP) to remove unincorporated dNTPs that 
may interfere with the subsequent cleavage reaction and methylation analyses. The reverse 
strands of the PCR products are then transcribed into a single-stranded RNA. The methylation 
dependent C/T changes introduced during bisulfite treatment should be represented as G/A 
changes in the RNA transcript. The transcript is then cleaved base specifically by RNase A, 
which cleaves at every U, and the cleavage products are analyzed by MALDI-TOF MS. Mass 
signals representing methylated and non-methylated DNA build signal pairs, each representative 
of the CpG site within the analyzed sequence substring. G/A changes in the RNA transcript lead 
to corresponding mass signals that shift 16Da for a methylation event. If two or more CpG sites 
are embedded within a cleavage product, mass signals may shift by multiples of 16Da. This 
diagram was taken from van den Boom and Ehrich [57]. 
3.8.1 Bisulfite Treatment of Sperm DNA Samples 
 The EZ DNA Methylation Kit (Zymo Research) was used for bisulfite treatment 
of 500ng of each genomic sperm DNA sample. Adding 100µL of M-Elution Buffer 
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(Zymo Research) resulted in a mean yield of 235ng of bisulfite-converted DNA for DNA 
methylation analysis. Bisulfite treatment introduces methylation dependent 
cytosine/uracil (C/U) sequence changes and each uracil is subsequently converted to 
thymidine (T) after PCR [57]. 
3.8.2 PCR Amplification of Imprinted Genes  
 Following bisulfite treatment, each of the three imprinted loci was amplified using 
imprinted primers (Integrated DNA Technologies) for the paternally-expressed imprinted 
genes PEG10 and SNURF and the maternally-expressed imprinted gene H19 
(Supplementary Table B.1) through qPCR. Individual 5µL PCR reactions were 
prepared using 2.5µL (1X) of 2X GoTaq Hot Start Colorless Master Mix, 1.0µL (0.2µM) 
of 1µM forward and reverse primer mix (Integrated DNA Technologies), and 1.5µL 
(3.5ng) of bisulfite-converted sperm DNA. The PCR reaction conditions were as follows: 
1) Hot start (95OC) for 2 minutes, and 2) 40 cycles of denaturing (95OC), annealing 
(58OC), and extension (72OC), each for 30 seconds. 
3.8.3 Shrimp Alkaline Phosphatase (SAP) Treatment 
 PCR products were then treated with shrimp alkaline phosphatase (SAP; 
Sequenom Item No. 10002.1) to remove unincorporated dNTPs. Keeping SAP enzyme 
on ice, SAP enzyme solution was prepared for each PCR product using 1.70µL nuclease-
free water and 0.30µL of SAP enzyme. After the PCR reactions were completed, 2µL of 
SAP enzyme solution were added to each sample. The samples were centrifuged at 3,000 
x g for 1 minute and incubated at 37OC for 20 minutes. The SAP enzyme was then 
inactivated at 85OC for 5 minutes before the samples were cooled and held at 4OC. 
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3.8.4 T7 Cleavage Transcription Protocol 
 A T Cleavage Transcription (T7) reaction was then performed to generate a 
single-stranded RNA molecule from the PCR product. The RNA strand is cleaved base 
specifically by RNase A after each uracil. Any C/T sequence changes introduced by 
bisulfite treatment are reflected as guanidine/adenine (G/A) changes on the reverse RNA 
strand, resulting in a mass difference of 16 Da for each CpG site enclosed in the cleavage 
products generated from the RNA transcript [57]. Briefly, a 5µL T Cleavage 
Transcription/RNase A mix was prepared for each reaction using 3.15µL of nuclease-free 
water, 0.89µL of 5X T7 Polymerase buffer (Sequenom Item No. 10059), 0.24µL of T 
Cleavage Transcription Mix (Sequenom Item No. 08051), 0.22µL of 100mM DTT 
(Sequenom Item No. 10062), 0.44µL of T7 RNA & DNA Polymerase (Sequenom Item 
No. 08050), and 0.06µL of RNase A (Sequenom Item No. 10061). After SAP reactions 
were completed, the SAP treated PCR samples were centrifuged at 540 x g for 1 minute 
before 2µL of T Cleavage Transcription/RNaseA mix was added to each sample. The 
samples were then centrifuged at 540 x g for 1 minute before they were incubated for 3 
hours at 37OC and held at 4OC overnight.  
3.8.5 Conditioning with Clean Resin and MassARRAY Analysis 
 After the T7 cleavage transcription reaction was completed, 20µL of nuclease-free 
water was added to each sample and the samples were centrifuged at 540 x g for 1 
minute. To each sample, 6mg of clean resin (Sequenom Item No. 08040) were then added 
to each sample. The samples were then taped to a rotator and allowed to rotate for 30 
minutes. After rotation was completed, the samples were centrifuged at 3,200 x g for 5 
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minutes and 10nL of each sample was dispensed onto a SpectroCHIP (Sequenom Item 
No. 01509) using the MassARRAY Nanodispenser (Sequenom Model # RS1000). 
Identification of methylated sites and determination of the degree of methylation for each 
imprinted locus was then assessed in the cleavage products containing the imprinted 
genes (PEG10, SNURF, and H19) using the MassARRAY Analyzer 4 (Sequenom Typ. 
PHX-1) matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) platform. The mass signals representing nonmethylated and 
methylated DNA form signal pairs, each representative of the CpG sites within the 
analyzed sequence substring. The relative amount of methylated DNA for each CpG site 
is then calculated from the ratio of the signal intensities for each pair [57]. The 
MassARRAY platform generates quantitative methylation results for each sequence-
defined analytical unit (either one individual CpG site or an aggregate of subsequent CpG 
sites), each referred to as a “CpG unit.” 
3.9 Statistical Analysis 
 Given the large error variances and imprecise estimates of measured parameters 
that would be produced from the small number of participants in our study (n = 3), we 
expected that the power to observe statistical differences in our results between treatment 
groups would be low. Therefore, we found it inappropriate to perform tests for statistical 
significance. Rather, we interpreted our results based on the consistency and magnitude 
of differences between treatment groups. 
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CHAPTER 4 
RESULTS 
4.1 Testing the Utility of Proteinase K Treatment 
 Figure 6 presents the comparison between lysing sperm cells in DNA/RNA 
Shield with 0.01M DTT and 0.01M DTT plus 75µg proteinase K for sperm samples 
obtained from two volunteers. The DNA concentration obtained after treating sperm 
sample 1 with 0.01M DTT plus 75µg proteinase K (mean = 33.4+0.21ng/µL) was 
marginally greater than that obtained after treatment with 0.01M DTT alone (mean = 
30.9+0.85ng/µL). On the other hand, the DNA concentration obtained after treating 
sperm sample 2 with 0.01M DTT plus 75µg proteinase K (mean = 28.9+0.00ng/µL) was 
marginally lower than that obtained after treatment with 0.01M DTT alone 
(30.1+0.28ng/µL). 
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Figure 6: Comparison of sperm DNA concentrations obtained from sperm samples from 
two healthy volunteers through DNA extraction after lysis in DNA/RNA Shield with either 
0.01M dithiothreitol (DTT) or 0.01M DTT and 75µg proteinase K. 
4.2 Testing the Effectiveness of Different Reducing Agents 
4.2.1 Sperm Cell Counting for Time-Course Experiment 
 Figure 7 presents the mean percentage of sperm cells remaining per mL cell 
suspension in DNA/RNA Shield over time after treatment with TCEP and DTT. 
Treatment of sperm cells with 100mM DTT resulted in a gradual decrease in the 
percentage of sperm cells/mL cell suspension observed over a period of 20 minutes, after 
which no sperm cells were visible. In comparison to DTT, there was a sharper decline in 
the percentage of sperm cells/mL cell suspension after treatment with 25mM TCEP over 
1 minute, after which no sperm cells were visible. There was no visible decline in the 
percentage of sperm cells after treatment with DNA/RNA Shield only over a period of 20 
minutes. 
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Figure 7: The mean percentage of sperm cells remaining per mL of cell suspension in 
DNA/RNA Shield over a period of 20 minutes after treatment with 25mM tris(2-
carboxyethyl)phosphine (TCEP) and 100mM dithiothreitol (DTT). 
4.2.2 Comparison of DNA Concentrations Obtained Using DTT and TCEP 
 Figure 8 presents the comparison of DNA concentrations obtained from sperm 
samples from two volunteers through DNA extraction after treatment with either 50mM 
DTT or TCEP reducing agents. There was an increase in the concentration of DNA 
obtained from both sperm samples after treatment with 50mM TCEP compared to 50mM 
DTT. Treatment with 50mM TCEP in sperm sample 1 resulted in a mean DNA 
concentration of 17.2+0.50ng/µL compared to a mean DNA concentration of 
12.6+0.28ng/µL after treatment with 50mM DTT. There was also an increase in the mean 
DNA concentration of sperm sample 2 after treatment with 50mM TCEP 
(21.3+0.71ng/µL) compared to 50mM DTT (12.3+0.35ng/µL). 
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Figure 8: Comparison of sperm DNA concentrations obtained from sperm samples from 
two healthy volunteers through DNA extraction after lysis with either 50mM dithiothreitol 
(DTT) or tris(2-carboxyethyl)phosphine (TCEP)reducing agents. 
4.3 Homogenization of Sperm Cells via QIAshredder 
 Figure 9 presents the comparison of sperm DNA concentrations obtained from 
sperm samples from two volunteers through DNA extraction after lysis with 50mM 
TCEP only or homogenization with QIAshredder columns followed by lysis with 50mM 
TCEP. There was an increase in the concentration of DNA obtained from both sperm 
samples after homogenizing with QIAshredder columns followed by lysis with 50mM 
TCEP compared to lysis with 50mM TCEP alone. QIAshredder coupled with TCEP in 
sperm sample 1 resulted in a mean DNA concentration of 25.9+0.35ng/µL compared to a 
mean DNA concentration of 18.6+0.99ng/µL after lysis with 50mM TCEP only. There 
was also a marked increase in the mean DNA concentration of sperm sample 2 after 
coupled treatment with QIAshredder and TCEP (21.7+0.49ng/µL) compared to 50mM 
TCEP only (12.3+0.35ng/µL). 
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Figure 9: Comparison of sperm DNA concentrations obtained from sperm samples from 
two healthy volunteers through DNA extraction after lysis with 50mM tris(2-
carboxyethyl)phosphine (TCEP) only or homogenization with QIAshredder followed by 
lysis with 50mM TCEP. 
4.4 Stability of Sperm DNA 
4.4.1 Sperm DNA Concentrations and Quality 
 Figure 10 compares the DNA concentrations attained from baseline and 4-week-
old sperm samples stored in DNA/RNA Shield at 4OC obtained from three volunteers 
after performing DNA extraction procedures involving QIAshredder and 50mM TCEP. 
The mean DNA concentration appeared to increase after 4 weeks of storage for sperm 
samples 1 (36.2+2.75 ng/µL to 40.0+2.98ng/µL) and 3 (32.2+1.38ng/µL to 
37.6+1.38ng/µL) but decrease for sperm sample 2 (44.3+3.93ng/µL to 38.7+3.93ng/µL) 
although these changes were minor. Overall, the amount of time sperm samples were 
stored in DNA/RNA Shield did not appear to show an effect on mean DNA 
concentrations attained. 
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Figure 10: Comparison of DNA concentrations attained from fresh and 4-week-old sperm 
samples obtained from three healthy volunteers stored in DNA/RNA Shield after 
performing DNA extraction procedures involving QIAshredder and 50mM tris(2-
carboxyethyl)phosphine (TCEP).  
 Table 2 shows the mean A260/A280 and A260/A230 ratios obtained for sperm 
samples stored in DNA/RNA shield at baseline after 4 weeks. A260/A280 ratios indicate 
possible contamination from proteins or phenols, and are expected to be in the range 1.8-
1.9 for pure DNA. The mean A260/A280 ratios for fresh and 4-week-old sperm samples 
ranged from 1.83 to 1.89. These ratios were similar between fresh and 4-week-old sperm 
samples. A260/A230 ratios are used as secondary measures of DNA purity and indicate 
possible contamination from ethylenediaminetetraacetic acid (EDTA), carbohydrates, or 
phenols. These ratios are expected to range from 2.0-2.2 for pure DNA. The mean 
A260/A230 ratios ranged from 0.67 to 1.76 and were also similar between fresh and 4-
week-old sperm samples. 
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Table 2: Mean A260/A280 and A260/A230 ratios for DNA extracted from fresh and 4-week-
old sperm samples obtained from three healthy volunteers. Sperm samples were suspended in 
DNA/RNA Shield and 50mM tris(2-carboxyethyl)phosphine (TCEP) before being homogenized 
using QIAshredder columns. Sperm DNA was then extracted from fresh and 4-week-old sperm 
samples using modified protocol from the Quick-gDNA MiniPrep Kit and quantified using 
Nanodrop 2000 Spectrophotometer. 
 
4.4.2 Restriction Digest and PCR of Sperm DNA 
 As a quality control procedure, we assessed the ability to perform downstream 
genetic analyses using DNA extracted from baseline and 4-week-old samples from one of 
the volunteers. Figure 11 presents a 0.7% agarose gel image of undigested genomic 
sperm DNA, ALU PCR product (446bp), and restriction digests of genomic sperm DNA 
using Hinf1 restriction enzyme for fresh and 4-week-old sperm DNA samples. The gel 
indicates that 1) genomic sperm DNA was visualized with equal band intensity from both 
fresh and 4-week-old sperm samples, indicated by the bands appearing greater than 24kb, 
2) ALU PCR product size was equal to that expected (446bp) and at equal band intensity 
for both fresh and 4-week-old sperm samples, and 3) equal and efficient digestion of 
sperm genomic DNA by Hinf1 enzymes, indicated by the equal intensity of streaks 
starting halfway down the gel. 
Fresh 4 weeks Fresh 4 weeks
Sample
Mean 
260/280 
(SD)
Mean 
260/280 
(SD)
Mean 
260/230 
(SD)
Mean 
260/230 
(SD)
1 1.88 (0.01) 1.87 (0.01) 1.25 (0.43) 1.03 (0.61)
2 1.84 (0.02) 1.87 (0.02) 0.67 (0.15) 0.67 (0.81)
3 1.89 (0.02) 1.83 (0.02) 1.76 (0.17) 1.27 (0.21)
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Figure 11: Electrophoresis of fresh and 4-week-old sperm DNA samples on 0.7% agarose 
gel. Legend: Lane 1 = 24kb DNA ladder, Lane 2= 100 bp DNA ladder, Lane 3 = undigested fresh 
genomic DNA, Lane 4 = undigested 4-week genomic DNA, Lane 5 = fresh ALU PCR product 
(446 bp), Lane 6 = 4-week ALU PCR product (446bp), Lane 7 = fresh Hinf1 digest, Lane 8 = 4-
week Hinf1 digest. 
4.4.3 DNA Methylation of Imprinted Genes 
 To evaluate the feasibility of DNA methylation analyses in sperm genomic DNA, 
and to rule out DNA contamination from somatic cells, we chose three imprinted genes 
for our analyses: two paternally-expressed imprinted genes (PEG10 and SNURF) and one 
maternally-expressed imprinted gene (H19). Somatic cells possess two alleles, each 
inherited from a different parent. Therefore, for imprinted genes, we would expect to find 
a mean methylation percentage of about 50% in somatic cells. Because we were 
investigating male gametes, each containing one allele for a given gene, we expected the 
allele of paternally-expressed imprinted genes to be unmethylated, and the allele of 
maternally-expressed imprinted genes to be fully methylated. 
 Bisulfite conversion of 500ng of genomic sperm DNA from the EZ DNA 
Methylation Kit resulted in a mean yield of 235ng of bisulfite-converted DNA used for 
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DNA methylation analysis. The degree of methylation at each CpG site for each sample 
in a given imprinted gene is summarized in an epigram (Figure 12). The mean 
percentage of methylation across the imprinted loci for each sample is summarized in 
Table 3. As expected, there was little to no methylation in SNURF and PEG10 while 
H19 was heavily methylated for each sample (Figure 12; Table 3). We also found that 
the mean percentages of methylation across all CpG sites were similar between fresh and 
4-week-old sperm samples for SNURF (1.43+1.02% and 1.55+0.95% respectively), 
PEG10 (3.69+0.66% and 4.28+1.52% respectively), and H19 (88.93+3.24% and 
91.78+2.00% respectively). 
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Figure 12: The degree of methylation at each CpG site for two paternally-expressed 
(SNURF and PEG10) and one maternally-expressed (H19) imprinted loci for DNA 
extracted from fresh (T0) and 4-week-old (T4) human sperm samples obtained from three 
healthy volunteers. Different letters (M or G) attached to the end of each sample indicate that the 
sample was run by a different individual. Red circles indicate no methylation, yellow circles 
indicate heavy methylation, and white circles indicate no analysis at their respective CpG sites. 
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Table 3: The mean percentage of methylation occurring across paternally-expressed 
imprinted loci (SNURF and PEG10) and maternally-expressed-imprinted loci (H19) for 
fresh and 4-week-old sperm samples obtained from three healthy volunteers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Fresh 4 weeks Fresh 4 weeks Fresh 4 weeks
1 1.21 (0.30) 1.07 (0.10) 3.94 (0.86) 3.00 (0.79) 84.92 (1.89) 92.13 (2.53)
2 2.29 (1.21) 1.50 (1.11) 4.06 (0.39) 3.83 (0.24) 90.67 (0.47) 91.50 (3.06)
3 0.79 (1.11) 2.07 (1.52) 3.06 (0.24) 6.01 (1.08) 91.21 (0.41) 91.71 (1.94)
Mean 1.43 (1.02) 1.55 (0.95) 3.69 (0.66) 4.28 (1.52) 88.93 (3.24) 91.78 (2.00)
Mean Percentage (%) 
Methylation across 
SNURF  Locus (SD)
Mean Percentage (%) 
Methylation across 
PEG10  Locus (SD)
Mean Percentage (%) 
Methylation across H19 
Locus (SD)
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
5.1 Optimization of Methods for Extraction of Human Sperm DNA 
5.1.1 Sperm Homogenization and Lysis Methods 
 We have optimized a rapid (5 minutes of cell lysis), cost-effective protocol for 
sperm cell lysis during DNA extractions. First, we eliminated the need for proteinase K 
during lysis of sperm cells involving high concentrations of guanidine thiocyanate in 
DNA/RNA Shield by demonstrating that there was no discernable change in DNA 
concentrations obtained after lysis treatment with proteinase K and DTT compared to 
DTT alone. Therefore, because proteinase K is unnecessary in the presence of high 
concentrations of guanidine thiocyanate in DNA/RNA Shield for the effective lysis of 
sperm cells, the costs of having to use proteinase K during DNA extractions are 
eliminated. Secondly, our results also suggest that TCEP is more effective at lysing 
sperm cells and results in greater yields of sperm DNA after 5 minutes of lysis at room 
temperature compared to DTT. This has desirable implications for clinical research 
because 1) the need for lengthy incubation steps (2 hours or more) involving heat is 
eliminated and 2) TCEP is odorless and 3) TCEP is more stable at room temperature 
compared to DTT [54], eliminating the need to prepare fresh aliquots of reducing agents 
for each DNA extraction and improving cost-efficiency of research. Finally, we 
optimized our lysis methods by demonstrating that using QIAshredder columns coupled 
with TCEP for homogenizing and lysing sperm cells produced greater yields of DNA 
compared to using TCEP alone. 
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5.1.2 Stability of Sperm DNA after 4 Weeks of Storage 
 Our optimized DNA extraction protocol produced comparable yields of DNA for 
fresh and 4-week-old sperm samples stored in DNA/RNA shield at 4OC. In addition, the 
A260/A280 ratios for fresh and 4-week-old sperm samples were similar and in the range 
between 1.8-1.9 expected for pure DNA, suggesting comparable DNA quality between 
these samples. A260/A230 ratios for fresh and 4-week-old sperm samples were also 
similar, but not in the expected range between 2.0-2.2 for pure DNA, suggesting the 
presence of residual EDTA during extraction procedures. However, because EDTA is 
used in commercial elution buffers to elute DNA used in many successful downstream 
analyses, it would not be expected to affect the quality of the DNA. 
 Our quality control analyses also revealed equal feasibility of downstream genetic 
and epigenetic analyses in fresh and 4-week-old sperm DNA samples. We found that 
genetic analyses using restriction digestion and PCR may be performed equally 
efficiently on sperm DNA extracted from both fresh and 4-week-old sperm samples. The 
ability to perform these analyses has wide ranging applications in assessing clinical 
markers of male reproductive health because reduced fidelity and efficiency of DNA 
repair mechanisms during spermatogenesis, due to age or environmental factors, may 
lead to harmful mutations in genes that are associated with adverse male reproductive 
health outcomes [22] as well as disease and autism spectrum disorders in the next 
generation [4-8]. 
 We were also able to measure methylation in bisulfite-converted sperm DNA for 
epigenetic analyses. The degree of DNA methylation was similar between fresh and 4-
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week-old sperm samples, indicating equal efficacy for DNA methylation analyses from 
fresh and 4-week-old sperm samples. In addition, we found little to no methylation in the 
two paternally-expressed imprinted genes (SNURF and PEG10), and heavy methylation 
in the maternally-expressed imprinted gene (H19). The magnitudes of methylation for the 
imprinted loci were also consistent with those found in previous literature for male 
gametes [58]. Therefore, we were able to rule out any contamination from somatic cells, 
where we would have expected to find approximately 50% methylation for either 
maternally-expressed or paternally-expressed imprinted genes. 
 Erasure of imprinting and methylation marks during gonadal sex determination 
and subsequent reestablishment of these marks during spermatogenesis represent critical 
windows of susceptibility during which environmental agents may adversely influence 
sperm epigenetic regulation [9]. A wide range of animal and epidemiological studies has 
linked exposure to endocrine disrupting chemicals during these susceptibility windows to 
adverse male reproductive health outcomes [59,60]. For example, exposure to phthalate 
metabolites at different doses in gestating F0 generation female rats during fetal gonadal 
sex determination has been shown to promote epigenetic inheritance of adverse health 
outcomes in male offspring such as pubertal abnormalities, testis disease, and 
obesity[10]. Analysis of the male F3 generation sperm epigenome revealed that aberrant 
methylation patterns were correlated with the pathologies identified. In addition, several 
epidemiological studies have linked exposure to phthalates to male infertility outcomes 
such as low sperm count, motility, and morphology [61-66], as well as reduction in 
fecundity specific to males [67]. Because alterations in the sperm epigenome have been 
associated with adverse male reproductive health outcomes [35], DNA methylation 
 44 
 
marks in sperm may provide part of the mechanistic pathway between environmental 
exposures and male reproductive health and inform more targeted treatment and 
intervention strategies to reduce the risk of these outcomes. 
5.2 Limitations 
5.2.1 Measurement Error 
 Variation in human measurements between sperm samples when performing 
DNA extraction protocol may have reduced the accuracy of resulting sperm DNA 
concentrations. However, because DNA extraction protocol was performed by the same 
experimenter under controlled conditions, any variation due to human error would be 
minimal. 
 In addition, because DNA methylation quality control preparations for PCR, SAP, 
and T7 reactions were conducted by two different experimenters, human error and 
variation in human measurements may have reduced the accuracy of methylation results. 
However, all reaction preparations were conducted by the experimenters at the same 
time, and reactions from both experimenters were run at the same time on the same 
instruments, thus minimizing the potential impact of this source of error. 
 Measurement error can also occur due to the imprecision inherent to the DNA 
methylation assays performed. However, because these assays follow a standardized 
protocol, any variation occurring in fresh sperm samples would cancel out the same 
variation occurring for 4-week-old samples. 
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5.2.2 Small Sample Size 
 All sperm samples were obtained from three healthy volunteers and used for our 
analyses. This small sample size may result in inaccurate estimates of differences in DNA 
yields, DNA quality, and degree of DNA methylation in imprinted genes between our 
fresh and 4-week-old sperm samples. This inaccuracy produces large standard errors so 
that the power to detect statistical differences between fresh and 4-week-old sperm 
samples would be reduced compared to larger sample sizes. Therefore, we found it 
inappropriate to perform any tests for statistical significance because the results of such 
tests would be virtually meaningless given our lack of statistical power. Future studies 
that utilize our optimized protocol using sufficiently large sample sizes to perform 
appropriate statistical tests would help to validate our results. 
5.2.3 Missing DNA Methylation Data 
 The MassARRAY (Sequenom) MALDI-TOF platform was unable to provide 
DNA methylation data for certain CpG sites in the imprinted genes we assessed. This 
typically occurs if the mass of a T7 cleavage product containing one or more CpG sites is 
too high or low to fall within the mass window of detection used by the MassARRAY 
platform. The lack of DNA methylation data could pose problems for analysis if the 
actual methylation levels for CpG sites in the undetected T7 cleavage products differ 
from those that were detected, impacting our quality control assessment. However, 
because only one imprinted allele is present for a given gamete, it is unlikely that the 
degree of methylation would vary by the number of T7 cleavage products detected for a 
given imprinted locus. 
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5.3 Future Assessments of Sperm Profiles for Clinical Research 
5.3.1 Importance of RNA in Sperm 
 A wide range of RNAs exist in mature human spermatozoa, from large messenger 
RNAs (mRNAs) [68] to small noncoding RNAs (sncRNAs) [69]. Mature spermatozoa 
are transcriptionally and translationally quiescent because they are devoid of intact 
ribosomal RNAs (rRNAs), including 28S and 18S transcripts [70]. Failure to observe 
rRNAs in sperm was previously attributed to the large reduction in cytoplasmic volume 
during spermiogenesis which expelled translational machinery [71,72]. However, recent 
studies using Next Generation Sequencing revealed that rRNA fragments abound, 
suggesting that cleavage (not expulsion of rRNA) is responsible for preventing spurious 
translation following spermiogenesis[73,74]. 
 Until recently, the observations of RNA in mature sperm were met with 
skepticism because of the view that the highly condensed sperm nucleus is 
transcriptionally inactive[70] and contamination from mitochondria or cytoplasmic 
residues could not be ruled out [75]. Advances in RNA extraction technologies in the late 
1990s using reverse transcriptase polymerase chain reaction (RT-PCR), in situ 
hybridization, and microarrays lacked any residual cytoplasm, mitochondria or somatic 
contaminants during preparations, thus ruling out any possible contamination [68,76-78]. 
The validity of all three methods was subsequently confirmed in a single study [79]. 
 Both mammalian and plant studies have identified many RNAs in sperm [80,81] 
and these RNAs have been associated with a wide range of biological processes [68,69]. 
These processes continue to be subject to investigation, but provide the first clues to 
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understanding the early events of post-fertilization and development. One generally 
accepted hypothesis is that paternally derived mRNAs remain translationally inactive in 
mature sperm, and some mRNAs are selectively retained until delivery to the oocyte [73]. 
The mechanism by which this occurs is the subject of much debate, but one possibility 
has been well characterized. During the final transcriptional period of spermiogenesis, 
several mRNAs are produced and then sequestered for storage as inactive messenger 
ribonucleoprotein particles (mRNPs) [82]. This sequestration is necessary for 
preservation of intact mRNAs before the sperm is delivered to the oocyte at fertilization. 
A study that compared transcripts retained in sperm from pooled and individual human 
ejaculates found the existence of a common spermatozoal mRNA fingerprint [68]. The 
RNA profile found included transcripts implicated in fertilization and development. 
These RNAs have since been independently observed in zygotes following fertilization 
[83]. The findings suggest that the RNAs retained in sperm and delivered to the oocyte at 
fertilization are not solely remnants of transcription during spermatogenesis, but may be 
essential for future embryonic development. 
 sncRNAs have also been suggested to play a role in regulating gene expression 
during spermatogenesis and future embryonic development, influencing offspring 
phenotype [84,85]. sncRNAs are approximately between 18 and 39 nucleotides in size 
and classified according to their biogenesis [86]. In somatic cells, these molecules 
function in post-transcriptional gene regulation, chromatin structure, and inhibiting 
transposition [73]. Small interfering RNAs (siRNA) and miRNAs are two of the most 
characterized classes of sncRNAs. Ranging in length from 20-24 nucleotides, these 
molecules are processed from loops in single-stranded DNA known as hairpins in 
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pathways involving the RNA-induced silencing complex (RISC) and DICER [73]. Data 
pertaining to sncRNAs in mature sperm have been largely uncharacterized to date. 
 A recent review highlighted that although miRNAs were the first class of 
sncRNAs observed in mammalian sperm, they account for only a small percentage (3%) 
of known sncRNAs aligned to the sperm genome [73]. Because post-transcriptional 
regulation of early embryonic development is strongly down-regulated during oocyte 
maturation and not required for preimplantation development [87,88], it is possible that 
paternal miRNAs and other sncRNAs delivered to the zygote bypass this regulatory 
pathway altogether. In somatic cells, sncRNAs bind to complimentary promoter regions, 
silencing gene transcription through the recruitment of PcG proteins and repressive 
histone marks [89]. The majority of miRNAs identified in sperm originate from promoter 
regions [73], suggesting that these transcripts may bind to paternal DNA during nuclear 
remodeling, influencing sperm chromatin structure, before being delivered to the oocyte. 
 In addition to siRNAs and miRNAs, the presence of piwi-interacting RNAs 
(piRNAs) has been demonstrated in spermatogenic cells [90]. Ranging in size from 26-30 
nucleotides, these sncRNAs are produced independent of DICER and RISC, not requiring 
double-stranded RNA folding [73]. Their function is essential to spermatogenesis 
because, complementary to transposons, these RNAs repress the rate of transposition, 
protecting the paternal genome from mobile elements [73]. Though assumed to be absent 
from mature sperm because of their function, a restricted set of piRNAs may be retained 
[73]. 
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 The potential applications of sperm RNAs have been summarized in a review 
[75]. The presence of RNAs in mature sperm indicates that the male gamete does not 
only serve as a vehicle for paternal DNA to the oocyte, but also carries key molecular 
markers in RNA, chromatin, and the nuclear matrix that are essential for proper 
embryonic development [73]. The presence or absence of the various stage-specific 
transcripts in mature sperm may provide a means to assess the fidelity of each stage of 
spermatogenesis. For example, PRM transcripts have been applied in clinics as their 
absence from ejaculate samples has been used to 1) confirm vasectomy and 2) diagnose 
male-factor infertility [75]. Overall, all RNAs reflect the transcriptional history of 
spermatogenic differentiation and their applications show great promise as a diagnostic 
tools. 
5.3.2 Extraction of Sperm RNA 
 The identification of RNA in mature spermatozoa, together with evidence linking 
its function to male fertility and future embryonic development [73,75,83], necessitated 
the development of reliable protocol to extract high-quality, high molecular weight RNA 
for downstream applications such as microarray profiling or PCR. The heterogeneous 
population of cells present in ejaculate and the small quantity of RNA present in cells 
(50fg of RNA/cell and 0.3fg of sncRNA/cell[55]) has represented some of the main 
challenges to the successful development of this protocol over several years[55,91,92]. 
Furthermore, because mature spermatozoa are transcriptionally and translationally 
quiescent, rRNA markers are virtually absent, hindering quality assessment. These 
challenges have necessitated 1) a purifying step to isolate only spermatozoa from a pool 
of somatic cell-containing ejaculate, 2) optimization of RNA extraction protocol to 
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maximize yield, and 3) the identification of new markers for sperm RNA quality 
assessment. 
 In the most recent protocol described by Goodrich et al. [55], a guanidinium 
thiocyanate-phenol-chloroform method to remove contaminating DNA was combined 
with Qiagen’s column-based RNeasy Mini and Minielute kits to obtain high-quality 
fractions of spermatozoal sncRNAs and mRNAs. The protocol incorporated β-
mercaptoethanol for cell lysis, nuclease-free stainless steel beads for homogenization 
using Disruptor Genie (Scientific Industries), and RNase block (Stratagene) to inhibit 
degradation from residual RNases.  
 Quality control was performed through Turbo DNase buffer (Ambion) treatment, 
reverse transcription, and PCR amplification with intron-spanning primers to verify the 
absence of genomic contamination and mRNA integrity[55]. Real-time PCR with PRM1 
primers showed that DNase-treated samples were void of amplification while only human 
genomic controls amplified, indicating that DNA contaminants were successfully 
removed. In addition, RNA integrity was assessed through two methods. First, reverse-
transcription of spermatozoal RNAs and subsequent real-time PCR on the cDNA 
products using PRM1 primers were performed. Products from cDNA amplification were 
smaller than products from DNA amplification because the PRM1 primers chosen were 
intron spanning [55]. Secondly, Bioanalyzer (Agilent) kits for total RNA and small RNA 
were used to verify 1) the absence of intact 18S and 28S rRNAs and 2) the presence of 
sncRNA respectively. The profiles showed that 18S and 28S rRNAs were undetectable, 
confirming their degradation, as well as the presence of sncRNAs as a rise in fluorescent 
units above background between 6 and 30 nucleotides in length [55]. 
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 While the recent methods published by Goodrich et al. [55] demonstrate the 
ability to yield high quality, high molecular weight RNA, these methods lack a means to 
stabilize the RNA for periods suitable for clinical research. We are currently developing a 
method for rapidly attaining high quality RNA from human sperm using similar 
stabilizing protocol from our DNA extraction methods. 
5.3.3 Sperm Histone Retention and Histone Modifications 
 A major subject of debate is whether selective post-meiotic retention of histones 
poises specific genomic regions of the sperm for early use during embryonic 
development. Initial evidence supporting this notion came from findings that showed 
histones bound to DNA in a sequence-specific manner around gene regulatory regions 
[93,94]. Isolation and interrogation of histone-associated sequences indicated that these 
regions include imprinted regions [95], telomeres [96,97], retroposon DNA [96], and 
specific gene loci [94,96,98]. In comparison to these regions, centromeric and 
pericentromeric regions of mammalian sperm have been found to lack histones, 
presenting a mix of histones and protamines [94]. 
 Recent advances in genome-wide analysis techniques now allow detection of 
histone-enriched regions at the primary sequence level. For example, CGH tiling arrays 
have associated histone-bound DNA with gene-dense regions, developmentally regulated 
promoters, and CTCF binding sites [99]. Next generation sequencing (NGS) exhibited 
even higher resolution analysis, revealing enrichment of histone-associated sequences at 
developmentally important genes such as spermatogenesis genes, embryonic transcription 
factors, and signaling machinery, as well as microRNA (miRNA) and imprinted gene 
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regions [34]. Further analyses revealed that internal exons also show significantly greater 
histone enrichment than intronic sequences, and histones were found to be distributed at 
relatively low levels outside of promoter regions [100]. It has also been proposed that 
histone-bound DNA retained in mature sperm mark sites of nuclear matrix attachment at 
scaffold/matrix attachment regions (S/MARs) anchoring decondensed DNA loops of 
prior cell types [36]. These markers may serve to deliver further information on paternal 
nuclear architecture to the zygote [36].  
 The promoters of developmental genes and certain noncoding RNAs in sperm 
have been associated with H3 Lysine 4 methylation (H3K4me3), a gene-activating 
histone modification, while lacking H3 Lysine 27 methylation (H3K27me3), a repressive 
histone modification [34]. On the other hand, promoters of genes encoding transcription 
factors important for embryonic development and morphogenesis bear two histone 
modifications with antagonistic roles: H3K4me3 and H3K27me3-together known as 
‘bivalent’ chromatin [34]. At these sites, large regions of H3K27me3 overlap with 
smaller regions of H3K4me3, potentially poising genes for either activation or repression 
later in development [101]. 
 Overall, these findings suggest that the sperm genome may be packaged and 
poised for two important processes: 1) spermatogenesis through active chromatin marks, 
and 2) future embryonic development through bivalent chromatin domains. These 
possibilities open new questions about whether various environmental and lifestyle 
factors may influence sperm histone modifications in a manner that impacts male fertility 
or future embryo development. The ability to perform sperm histone modification 
analysis has been demonstrated using standard chromatin immunoprecipitation (ChIP) 
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assays [34,101]. Whether our sperm stabilization methods are compatible with these 
assays for clinical research warrants further study. 
5.4 Conclusions 
 We have optimized methods to extract human sperm DNA rapidly under simple 
conditions, eliminating the need for costly, inefficient alternative protocol not ideal for 
clinical research. Furthermore, storing sperm samples in DNA/RNA shield at 4OC 
stabilized sperm DNA mass and quality over a period of 4 weeks. This stability increases 
the cost-efficiency of clinical research because it minimizes the need to produce fresh 
sperm DNA samples for each downstream genetic and epigenetic application. 
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APPENDIX A 
HUMAN SPERM CELL ISOLATION AND DNA EXTRACTION 
A.1 Materials 
PureCeption 100% Isotonic Solution   SAGE Ref # ART-2100 
Quinn’s Sperm Washing Medium   SAGE Ref # ART-1006 
DNA/RNA Shield     Zymo Research Cat # R1100-1-50 
Bond-Breaker TCEP Solution Neutral pH, 0.5M Thermo Scientific Prod # 77720 
Pulse Vortex Mixer     Fisher Scientific Cat # 02215375 
QIAshredder      Qiagen Cat # 7965 
Quick-gDNA MiniPrep Kit    Zymo Research Cat # D3025 
A.2 Sperm Cell Isolation Protocol 
1. Bring PureCeption 100% Isotonic Solution and Quinn’s Sperm Washing Medium 
to 37OC before use. Make a 90% PureCeption solution by adding 1 volume of 
Quinn’s Sperm Washing Medium to 9 volumes of PureCeption 100% Isotonic 
Solution. 
 
2. Add 1.0mL of 90% PureCeption to a 15mL conical centrifuge tube. 
 
3. Gently layer 1.5-2.0mL of fresh liquefied semen on top of the 90% PureCeption 
using a transfer pipette. There should be no mixing of the sample and the 90% 
PureCeption. If the semen volume is more than 2.0mL, use more than one tube of 
90% PureCeption. 
 
4. Centrifuge at 500 x g for 30 minutes. 
 
5. Using a pipette, carefully remove the 90% PureCeption and seminal fluid without 
disturbing the sperm pellet, leaving a small amount of 90% PureCeption over the 
sperm pellet. Aspirate from the top downward, always keeping the pipette tip just 
below the fluid surface. If no sperm pellet is clearly visible, remove all but 0.5mL 
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of the 90% PureCeption layer. This will allow for the collection of sperm 
suspended in the 90% PureCeption. Transfer the sperm pellet in this residual 
medium to a clean conical centrifuge tube for further washing. 
 
6. Using a pipette, add 4mL of Quinn’s Sperm Washing Medium and resuspend the 
pellet by gently tapping with your fingers. 
 
7. Centrifuge the mixture at 500 x g for five minutes to wash away residual 90% 
PureCeption solution. 
 
8. Placing the pipette to the bottom of the tube, remove 1mL of washed sample and 
place in a new 1.5mL microcentrifuge tube. 
 
9. Centrifuge the tube for 1 minute at maximum speed and then carefully remove the 
supernatant. 
 
10. Resuspend the sperm pellet in 900µL of DNA/RNA shield and 100µL (50mM) of 
0.5M TCEP. Mix and incubate at room temperature for 5 minutes with occasional 
vortexing using the Pulse Vortex Mixer. 
 
11. Centrifuge half the volume of mixture in a QIAshredder column twice for 2 
minutes at maximum speed. If the sperm cells will not be used immediately, cells 
in DNA/RNA shield can be stored at 4OC for up to a month. 
 
A.3 Sperm DNA Isolation Protocol 
1. Add Genomic Lysis Buffer from the Quick-gDNA MiniPrep Kit to the mixture in 
a 3:1 ratio. 
 
2. Transfer the mixture to a Zymo-Spin Column in a Collection Tube. Centrifuge at 
10,000 x g for one minute. Discard the Collection Tube with the flow through. 
 
3. Transfer the Zymo-Spin Column to a new Collection Tube. Add 200µL of DNA 
Pre-Wash Buffer to the spin column. Centrifuge at 10,000 x g for one minute. 
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4. Add 500µL of g-DNA Wash Buffer to the spin column. Centrifuge at 10,000 x g 
for one minute. Repeat this step once and then incubate at room temperature for 
five minutes. 
 
5. Transfer the spin column to a clean microcentrifuge tube. Add 100µL DNA 
Elution Buffer to the spin column. Incubate for 3 minutes at room temperature 
and then centrifuge at maximum speed for 30 seconds to elute the DNA. If the 
DNA will not be used immediately, store at 4OC. 
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APPENDIX B 
SUPPLEMENTARY TABLES AND FIGURES 
Table B.1: Primers used to amplify ALU, SNURF, PEG10, and H19 loci by PCR from DNA 
extracted from human sperm samples. ALU was amplified from non-bisulfite-converted DNA 
for assessment of PCR amplification and the imprinted loci SNURF, PEG10, and H19 were 
amplified from bisulfite converted DNA for DNA methylation analysis. Underlined sequences in 
lowercase letters represent the T7-promoter tagged reverse primer for in vitro transcription and a 
10mer-tag sequence added to the forward primer to balance the PCR primer length. 
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